Is SUSRF or O a better dividend investment in 2026?

SUSRF currently yields 70.42% with a 5% 5-year dividend growth rate. O yields 5.28% with 3.2% growth. The better choice depends on your goal: SUSRF offers higher current income.

What is the dividend yield difference between SUSRF and O?

SUSRF has a forward dividend yield of 70.42% ($2.00/share annually). O yields 5.28% ($3.23/share annually). The yield gap is 65.14 percentage points.

Home › Compare › SUSRF vs O

SUSRF vs O: Dividend Comparison 2026

SUSRF yields 70.42% · O yields 5.28%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SUSRF wins by $1.04M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SUSRF

● Live price

70.42%

Share price

$2.84

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.07M

Annual income

$282,657.96

Full SUSRF calculator →

Realty Income Corporation

● Live price

5.28%

Share price

$61.18

Annual div

$3.23

5Y div CAGR

15.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$34.2K

Annual income

$5,098.20

Full O calculator →

Portfolio growth — SUSRF vs O

📍 SUSRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SUSRF	O
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SUSRF + O cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SUSRF pays

O pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SUSRF

Annual income on $10K today (after 15% tax)

$5,985.92/yr

After 10yr DRIP, annual income (after tax)

$240,259.27/yr

Annual income on $10K today (after 15% tax)

$448.90/yr

After 10yr DRIP, annual income (after tax)

$4,333.47/yr

At 15% tax rate, SUSRF beats the other by $235,925.80/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SUSRF + O for your $10,000?

SUSRF: 50%O: 50%

100% O50/50100% SUSRF

Portfolio after 10yr

$553.2K

Annual income

$143,878.08/yr

Blended yield

26.01%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

SUSRF

No analyst data

Altman Z

2.7

Piotroski

6/9

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$64.00

+4.6% upside vs current

Range: $60.00 — $69.00

Altman Z

1.0

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SUSRF buys

O buys

No recent congressional trades found for SUSRF or O in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSUSRFO

Forward yield	70.42% ✓	5.28%
Annual dividend / share	$2.00	$3.23 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	15.1% ✓
Portfolio after 10y	$1.07M	$34.2K ✓
Annual income after 10y	$282,657.96 ✓	$5,098.20
Total dividends collected	$914.3K ✓	$20.7K
Payment frequency	quarterly	monthly
Sector	Stock	REIT

Year-by-year: SUSRF vs O ($10,000, DRIP)

Year	SUSRF Portfolio	SUSRF Income/yr	O Portfolio	O Income/yr	Gap
1← crossover	$17,742	$7,042.25	$10,818	$607.86	+$6.9K → SUSRF
2	$30,661	$11,677.14	$11,786	$741.30	+$18.9K → SUSRF
3	$51,667	$18,859.73	$12,944	$910.50	+$38.7K → SUSRF
4	$84,985	$29,701.39	$14,343	$1,127.28	+$70.6K → SUSRF
5	$136,593	$45,658.47	$16,053	$1,408.17	+$120.5K → SUSRF
6	$214,738	$68,583.71	$18,167	$1,776.65	+$196.6K → SUSRF
7	$330,537	$100,766.97	$20,815	$2,266.60	+$309.7K → SUSRF
8	$498,633	$144,958.95	$24,179	$2,927.66	+$474.5K → SUSRF
9	$737,910	$204,372.63	$28,521	$3,833.95	+$709.4K → SUSRF
10	$1,072,222	$282,657.96	$34,218	$5,098.20	+$1.04M → SUSRF

SUSRF vs O: Complete Analysis 2026

SUSRF — Stock

Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; simbionix simulators; and robotic surgery simulators. Surgical Science AB was founded in 1999 and is headquartered in Gothenburg, Sweden.

Full SUSRF Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →

📬

Get this SUSRF vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SUSRF vs SCHD SUSRF vs JEPI SUSRF vs KO SUSRF vs MAIN SUSRF vs STAG SUSRF vs ADC SUSRF vs NNN SUSRF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.